Citigroup’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.68K | Hold |
796
| – | – | ﹤0.01% | 4592 |
|
|
2025
Q1 | $1.21K | Sell |
796
-1,501
| -65% | -$2.28K | ﹤0.01% | 4578 |
|
|
2024
Q4 | $5.05K | Buy |
2,297
+1,501
| +189% | +$3.3K | ﹤0.01% | 4596 |
|
|
2024
Q3 | $1.98K | Sell |
796
-3,891
| -83% | -$9.69K | ﹤0.01% | 4594 |
|
|
2024
Q2 | $6K | Sell |
4,687
-801
| -15% | -$1.03K | ﹤0.01% | 4479 |
|
|
2024
Q1 | $15.9K | Buy |
5,488
+1,721
| +46% | +$4.97K | ﹤0.01% | 4347 |
|
|
2023
Q4 | $27.7K | Buy |
3,767
+3,078
| +447% | +$22.6K | ﹤0.01% | 4099 |
|
|
2023
Q3 | $5.29K | Sell |
689
-5,847
| -89% | -$44.9K | ﹤0.01% | 3978 |
|
|
2023
Q2 | $66.3K | Buy |
6,536
+6,236
| +2,079% | +$63.2K | ﹤0.01% | 3803 |
|
|
2023
Q1 | $2.91K | Sell |
300
-103
| -26% | -$1K | ﹤0.01% | 4335 |
|
|
2022
Q4 | $1.96K | Sell |
403
-3,806
| -90% | -$18.5K | ﹤0.01% | 4479 |
|
|
2022
Q3 | $60K | Buy |
4,209
+3,280
| +353% | +$46.8K | ﹤0.01% | 3599 |
|
|
2022
Q2 | $6K | Sell |
929
-599
| -39% | -$3.87K | ﹤0.01% | 4787 |
|
|
2022
Q1 | $9K | Sell |
1,528
-1,430
| -48% | -$8.42K | ﹤0.01% | 4789 |
|
|
2021
Q4 | $48K | Buy |
2,958
+1,712
| +137% | +$27.8K | ﹤0.01% | 4317 |
|
|
2021
Q3 | $33K | Buy |
+1,246
| New | +$33K | ﹤0.01% | 4231 |
|